November 14, 2025

The Risk Factor Going Unscreened

Adverse childhood experiences drive elevated all-cause mortality across medical conditions, with emergency department patients also showing nearly double the death rates.

Conexiant

November 12, 2025

Dual Therapy for Coronary Disease: How Safe Is It? 

Adding aspirin to long-term oral anticoagulation in patients with chronic coronary syndrome increased mortality and major bleeding without improving cardiovascular outcomes.

Conexiant

November 12, 2025

Adverse Pregnancy Outcomes Offer Early Clues to Future AF

Researchers found that adverse pregnancy outcomes increase women’s long-term risk of atrial fibrillation.

Conexiant

November 11, 2025

Gene Editing Lowers Cholesterol in Early Trial

At the highest tested dose, a single IV CRISPR therapy reduced LDL cholesterol by ~49% and triglycerides by ~55% at 60 days in patients with treatment-resistant dyslipidemia.

Conexiant

November 10, 2025

FDA Proposes Removal of Box Warnings

The FDA proposed updates to menopausal hormone therapy labeling to reflect current evidence on benefits and risks.

Conexiant

November 04, 2025

Should SGLT-2 Inhibitors Be Continued After a UTI?

Patients with type 2 diabetes who developed urinary tract infections while taking sodium-glucose cotransporter-2 inhibitors faced higher heart and kidney risks.

Conexiant

November 04, 2025

Why Do Women Need Less Exercise for the Same Heart Benefit?

Accelerometer data from over 85,000 UK Biobank participants reveal significant sex differences in physical activity benefits for heart disease prevention and survival.

Conexiant

October 30, 2025

Viral Infections Increase Cardiovascular Disease Risk 

Systematic review identifies influenza, COVID-19, HIV, hepatitis C, and herpes zoster as significant cardiac risk factors in analysis of 155 studies.

Conexiant

October 29, 2025

FDA Pushes Faster, Cheaper Route for Biosimilar Approval

The FDA released new draft guidance to streamline biosimilar development.

Conexiant